Cite
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
MLA
Jonathan J Deeks, et al. “Comparing Biparametric to Multiparametric MRI in the Diagnosis of Clinically Significant Prostate Cancer in Biopsy-Naive Men (PRIME): A Prospective, International, Multicentre, Non-Inferiority within-Patient, Diagnostic Yield Trial Protocol.” BMJ Open, vol. 13, no. 4, Apr. 2023. EBSCOhost, https://doi.org/10.1136/bmjopen-2022-070280.
APA
Jonathan J Deeks, Chris Brew-Graves, Yemisi Takwoingi, Aiman Haider, Clare Allen, Alex Freeman, Mark Emberton, Antti Rannikko, John Wilkinson, Daniel Margolis, Enrique Gomez Gomez, Sangeet Ghai, Alex Kirkham, Veeru Kasivisvanathan, Caroline M Moore, Hazel McBain, Anders Bjartell, Paula Lorgelly, Pramit Khetrapal, … Joke Van Egmond. (2023). Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open, 13(4). https://doi.org/10.1136/bmjopen-2022-070280
Chicago
Jonathan J Deeks, Chris Brew-Graves, Yemisi Takwoingi, Aiman Haider, Clare Allen, Alex Freeman, Mark Emberton, et al. 2023. “Comparing Biparametric to Multiparametric MRI in the Diagnosis of Clinically Significant Prostate Cancer in Biopsy-Naive Men (PRIME): A Prospective, International, Multicentre, Non-Inferiority within-Patient, Diagnostic Yield Trial Protocol.” BMJ Open 13 (4). doi:10.1136/bmjopen-2022-070280.